MARK BARATS M.D. NPI 1720134695

NPI Details

Mark Barats, M.D. is a nephrology internal medicine in West Hollywood, CA with 41 years of experience. The provider is an internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation. Mark Barats, M.D. NPI is 1720134695. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

948 N FAIRFAX AVE
# 201
WEST HOLLYWOOD, CA
ZIP 90046-204
Phone: (323) 654-2020
Fax: (323) 654-2828

The NPI 1720134695 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D2020377 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Urinalysis, manual test (HCPCS:81002)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Removal of impacted ear wax (HCPCS:69210)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS:95251)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment (HCPCS:95250)
• Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram (HCPCS:J7644)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 1/25/2007 and was last updated on 5/5/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.